ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

2015 - Marketing Products Without Getting Hammered by FDA - 2-day Comprehensive Workshop

Date2015-03-05 - 2015-03-06

Deadline2015-03-05

VenueDoubleTree by Hilton Baltimore - BWI Airport, USA - United States USA - United States

KeywordsMedical Device; Pharmaceutical; Aerospace

Websitehttps://www.globalcompliancepanel.com

Topics/Call fo Papers

Overview:
With this seminar you will learn how to navigate FDA's legal requirements and its interpretations for enforcement purposes. The agency now applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This becomes a new factor in trying to stay within FDA's legal corral.
This conference will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept. You will learn how corporate management requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments. You will understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. Most importantly, you will understand the boundaries that FDA uses and how easy it is to cross them. With information from this course, you can step back and rationally evaluate your firm's regulatory profile for advertising and promotion.
Why should you attend:
If you go "off label" with advertising and promotion, you become embroiled in FDA's advertising and promotion requirements. For devices, the law is weak and lacks legal clarity. For drugs, FDA's law and regulations are extensive and have violated Constitutional protections. Depending on your point of FDA's promotion and advertising requirements can help you or hurt you? There is an inherent conflict in interests. In any case, you need to identify practical criteria to make marketing decisions. That begs the question of whether or not marketing managers and regulatory affairs managers will even try to agree on an issue. FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. CDER has established a pervasive and expanding program. For example, policing social media has become a new regulatory responsibility. Bottom line, do you know when you are running afoul of FDA's requirements or are you guessing? It's become a brooding nightmare for you and consumers.
Areas Covered in the Session:
FDA's legal authority and Constitutional limitations
FDA requirements and exemptions
FDA guidance documents, such as for social media, direct-to-onsumer advertising, message formatting and providing risk/benefit information
Warning Letters
Who will benefit:
Managers for:
Regulatory Affairs
Quality Assurance
Manufacturing
FDA consultants and legal counsel
Agenda:
Day One
Lecture 1: FDA legal authority
FTC / mass media
DOJ / False Claims
FDA application of the FD&C statute and regulations
False and Misleading
Lecture 2: Cognitive psychology
Lecture 3: Promotion and Advertising: scope of labeling
Definitions for "label" and "labeling"
Hard copy and electronic
Testimonials
Blogs
Sales force
What is "off-label"?
Practice of Medicine exemption
Drugs authority
Devices
Dietary supplements
Lecture 4: Supreme Court / commercial free speech
Constitutional protection
Safe harbor
Lecture 5: Policy
FDA organizational responsibility
FDA Guidance
Balanced disclosure of risk vs. benefit
Social Media
Direct to Consumer Advertising
Day Two:
Lecture 6: Hypothetical Workshop
Direct to consumer advertising
Federal Trade Commission authority
Fair and balanced information
Context and format
Script versus message
Target population
Aspirations
Emotional factors
False and misleading information
Statutory basis (21 U.S.C. 352(a))
New use
Comparative claims
Claims for safety and effectiveness
Sales for solicitation
Off label use
(Group Hypothetical)
Lecture 7: FDA Warning Letters
Lecture 8: Corporate management responsibility
FDA - false and misleading
FTC - false advertising
DOJ - false claims
Speaker:
Casper Uldriks through his firm "Encore Insight LLC," brings over 32 years of experience from the FDA. As an investigator, he was responsible for countless 483s,
scores of Warning Letters, injunctions, individual seizures, mass seizures and was coined by industry as FDA's "Darth Vader.
Quick Contact:
GlobalCompliancePanel
USA Phone: 1-800-447-9407
Fax: 302-288-6884
support-AT-globalcompliancepanel.com
http://www.globalcompliancepanel.com

Last modified: 2015-02-06 13:59:11